Effect of large intermittent intravenous doses of cyclophosphamide in lymphoma.
作者信息
Mendelson D, Block J B, Serpick A A
出版信息
Cancer. 1970 Mar;25(3):715-20. doi: 10.1002/1097-0142(197003)25:3<715::aid-cncr2820250332>3.0.co;2-9.
Abstract
摘要
相似文献
1
Effect of large intermittent intravenous doses of cyclophosphamide in lymphoma.
Cancer. 1970 Mar;25(3):715-20. doi: 10.1002/1097-0142(197003)25:3<715::aid-cncr2820250332>3.0.co;2-9.
2
High dose imtermittent intravenous cyclophosphamide in non-Hodgkin's lymphomas: long-term patient follow-up.
Oncology. 1976;33(4):170-2. doi: 10.1159/000225136.
3
Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
S Afr Med J. 1966 Dec 10;40(44):1061-4.
4
[Intermittent high-dosage cyclophosphamide therapy].
Bratisl Lek Listy. 1970 Mar;53(3):329-32.
5
Mechlorethamine HCl and cyclophosphamide in the treatment of Hodgkin's disease and the lymphomas.
JAMA. 1968 Feb 5;203(6):392-8.
6
7
[Personal experience on the chemotherapy of leukemias and hematosarcomas].[白血病和血液肉瘤化疗的个人经验]
Acta Genet Med Gemellol (Roma). 1968 Jan;17(1):245-54.
8
[Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
Ann Med Interne (Paris). 1977 May;128(5):493-6.
9
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.环磷酰胺、长春新碱和泼尼松联合治疗恶性淋巴瘤。
Cancer. 1971 Aug;28(2):306-17. doi: 10.1002/1097-0142(197108)28:2<306::aid-cncr2820280208>3.0.co;2-n.
10
Treatment of malignant lymphomas with methyl ester of streptonigrin (NSC 45384).
Cancer. 1966 Oct;19(10):1377-85. doi: 10.1002/1097-0142(196610)19:10<1377::aid-cncr2820191008>3.0.co;2-l.
引用本文的文献
1
Hair disorders in patients with cancer.癌症患者的毛发疾病。
J Am Acad Dermatol. 2019 May;80(5):1179-1196. doi: 10.1016/j.jaad.2018.03.055. Epub 2018 Apr 14.
2
Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics.环磷酰胺与二甲基亚砜治疗肺鳞状细胞癌。治疗效果、毒性及药代动力学。
Cancer Chemother Pharmacol. 1981;6(2):117-20. doi: 10.1007/BF00262327.
3
Excretion patterns of alkylating metabolites in urine following cyclophosphamide treatment of tumor patients: influence of application route, dosage, liver and kidney function.
J Cancer Res Clin Oncol. 1979 Jul 27;94(3):277-86. doi: 10.1007/BF00419287.
Zotero 插件